Related Experiment Video
Updated: May 15, 2025

10:46
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
Published on: May 2, 2016
6.8K
Design and Biodistribution of PEGylated Core-Shell X-ray Fluorescent Nanoparticle Contrast Agents
Giovanni M Saladino1,2, Bertha Brodin1, Mihai Ciobanu1
1Department of Applied Physics, School of Engineering Sciences, KTH Royal Institute of Technology, Stockholm, SE 10691, Sweden.
ACS Applied Materials & Interfaces
|April 23, 2025
Summary
Surface modification of nanoparticles with polyethylene glycol (PEG) impacts their distribution in vivo. Chemisorbed PEG reduced liver uptake, while physisorbed PEG had minimal effect, highlighting X-ray fluorescence imaging for nanoparticle assessment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Radiology
Background:
- Nanoparticle (NP) accumulation in organs like the liver and spleen hinders targeted delivery for bioimaging and therapeutics.
- Polyethylene glycol (PEG) surface functionalization is a strategy to reduce NP sequestration, but its in vivo stability and biodistribution impact require further investigation.
- X-ray fluorescence (XRF) imaging offers noninvasive, quantitative in vivo mapping of elemental biodistribution with high resolution and penetration.
Purpose of the Study:
- To investigate the role of chemisorbed versus physisorbed PEG on silica-coated molybdenum-based contrast agents in affecting their in vivo biodistribution.
- To quantitatively assess the impact of PEGylation strategies on nanoparticle uptake by organs using whole-body XRF imaging.
- To establish a foundation for developing strategies to mitigate undesired nanoparticle uptake.
Main Methods:
- Stepwise layering approach for synthesizing silica-coated molybdenum-based contrast agents.
- Whole-body XRF imaging for noninvasive, quantitative in vivo biodistribution analysis.
- Comparative studies using physisorbed PEG (1.5 kDa) and chemisorbed mPEG-Si (6-9 PEG units).
- Multiscale imaging with fluorophore-doped silica shells for microscopic validation.
Main Results:
- Physisorbed PEG did not significantly alter nanoparticle biodistribution.
- Chemisorbed PEG significantly reduced NP uptake in the liver.
- The spleen compensated for reduced liver sequestration, as validated microscopically.
- XRF imaging proved effective for rapid, quantitative in vivo pharmacokinetic assessment of functionalized contrast agents.
Conclusions:
- The method of PEG attachment (chemisorption vs. physisorption) critically influences nanoparticle biodistribution in vivo.
- Chemisorption of PEG offers a promising strategy to reduce liver sequestration of nanoparticles.
- XRF imaging is a valuable tool for evaluating nanoparticle surface modifications and guiding the development of targeted delivery systems.
Keywords:
PEGylationX-ray fluorescencebiodistributioncontrast agentscore−shell nanoparticlesnanomedicinesurface functionalization
